A randomized phase II study of secondary cytoreductive surgery in patients with relapsed ovarian cancer who have progressed on a PARP inhibitor as first-line maintenance therapy: the SOCCER-P study (KGOG 3067/JGOG 3036/APGOT-OV11).
Hyun Woong ChoHee Seung KimJeong-Yeol ParkYoo Young LeeMyong Cheol LimSung-Jong LeeKyung-Jin MinKyung Jin EohKwang Beom LeeMin Kyu KimJae Yun SongSeung-Hyuk ShimYong Il JiYong-Joong SongSuk-Joon ChangMi-Kyung KimAkiko AbeYusuke KobayashiHiroaki KajiyamaMuneaki ShimadaAikou OkamotoJoseph Soon Yau NgJung-Yun LeePublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
NCT05704621.
Keyphrases
- phase ii study
- minimally invasive
- open label
- acute lymphoblastic leukemia
- locally advanced
- acute myeloid leukemia
- coronary artery bypass
- dna damage
- diffuse large b cell lymphoma
- dna repair
- multiple myeloma
- randomized controlled trial
- clinical trial
- stem cells
- radiation therapy
- surgical site infection
- oxidative stress
- coronary artery disease
- mesenchymal stem cells
- acute coronary syndrome